[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
The copper-bound form is the version most commonly referenced in published peptide research literature, as the copper coordination is central to its studied activity
Its also used to protect the liver against toxins like amatoxin, which is produced by the death cap mushroom and is deadly if ingested
Results & lasting results
Potential side effects are usually associated with higher doses and may include mild digestive issues, especially when starting supplementation
BPC-157 Mechanisms Stimulates angiogenesis (formation of new blood vessels) to injured areas